Complementary and Alternative Medicine Treatments for Generalized Anxiety Disorder: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Study Goal
The researchers aimed to evaluate the efficacy and safety of balneotherapy compared to paroxetine in treating generalized anxiety disorder (GAD).
Results Summary
The study found that balneotherapy was superior to paroxetine in one quality trial involving 237 participants over 8 weeks, indicating efficacy for GAD. However, safety reporting was poor, and broader evidence for CAM methods in GAD remains limited.
Population
Adults diagnosed with generalized anxiety disorder (GAD) according to standard criteria.
Effective Dosage
Not specified
Duration
8 weeks
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Kava Kava (Piper methysticum) extracts | decrease | end-of-treatment Hamilton Anxiety scale score | adults with generalized anxiety disorder | - 3.24 (95% CI - 6.65, 0.17; P = 0.059) | suggested a modest effect | #1 |
Lavender (Lavandula angustifolia) extract | decrease | generalized anxiety disorder severity | adults with generalized anxiety disorder | - | were superior to placebo | #2 |
combination of extracts of C. oxycantha, E. californica and magnesium | decrease | generalized anxiety disorder severity | adults with generalized anxiety disorder | - | were superior to placebo | #3 |
balneotherapy | decrease | generalized anxiety disorder severity | adults with generalized anxiety disorder | - | was superior to paroxetine | #4 |
INTRODUCTION: The objective was to evaluate efficacy/safety of complementary and alternative medicine (CAM) methods for generalized anxiety disorder (GAD) based on randomized controlled trials in adults. METHODS: Data sources. Six electronic databases ("generalized anxiety (disorder)" and "randomized trial") and reference lists of identified publications were searched to March 2017. STUDY SELECTION: Eligibility: full-text publications (English, German language); CAM versus conventional treatment, placebo/sham or no treatment; GAD diagnosed according to standard criteria; and a validated scale for disease severity. Of the 6693 screened records, 32 were included (18 on biologically-based therapies, exclusively herbal preparations; eight on manipulative and body-based therapies; and three on alternative medical systems and three on mind-body therapies). DATA EXTRACTION: Cochrane Collaboration methodology was used for quality assessment and data extraction. RESULTS: Direct comparisons of Kava Kava (Piper methysticum) extracts to placebo (4 quality trials, n = 233) were highly heterogeneous. Network meta-regression reduced heterogeneity and suggested a modest Kava effect [end-of-treatment Hamilton Anxiety scale score difference adjusted for baseline scores and trial duration: - 3.24 (95% CI - 6.65, 0.17; P = 0.059), Kava Kava 4 arms, n = 139; placebo 5 arms, n = 359]. Lavender (Lavandula angustifolia) extract (1 quality trial, 10 weeks, n = 523) and a combination of extracts of C. oxycantha, E. californica and magnesium (1 quality trial, 12 weeks, n = 264) were superior to placebo and balneotherapy was superior to paroxetine (1 quality trial, 8 weeks, n = 237) indicating efficacy. All other trials were small and/or of modest/low quality and/or lacked assay sensitivity. Safety reporting was poor. CONCLUSION: Evidence about efficacy/safety of most CAM methods in GAD is limited. Apparent efficacy of certain herbal preparations and body-based therapies requires further confirmation.